Casey Eye Institute, Oregon Health and Science University, Portland.
Optovue Inc, Fremont, California.
JAMA Ophthalmol. 2018 Aug 1;136(8):929-936. doi: 10.1001/jamaophthalmol.2018.2257.
Diabetic retinopathy (DR) is a leading cause of vision loss that is managed primarily through qualitative clinical examination of the retina. Optical coherence tomography angiography (OCTA) may offer an objective and quantitative method of evaluating DR.
To quantify capillary nonperfusion in 3 vascular plexuses in the macula of eyes patients with diabetes of various retinopathy severity using projection-resolved OCTA (PR-OCTA).
DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study at a tertiary academic center comprising 1 eye each from healthy control individuals and patients with diabetes at different severity stages of retinopathy. Data were acquired and analyzed between January 2015 and December 2017.
Foveal avascular zone area, extrafoveal avascular area (EAA), and the sensitivity of detecting levels of retinopathy.
The study included 39 control individuals (20 women [51%]; mean [SD] age, 43.41 [19.37] years); 16 patients with diabetes without retinopathy (8 women [50%]; mean [SD] age, 56.50 [12.43] years); 23 patients with mild to moderate nonproliferative DR (18 women [78%] ; mean [SD] age, 62.48 [10.55] years); and 32 patients with severe nonproliferative DR or proliferative DR (12 women [38%]; mean age, 53.41 [14.05] years). Mean (SD) foveal avascular zone area was 0.203 (0.103) mm2 for control individuals, 0.192 (0.084) mm2 for patients with diabetes without retinopathy, 0.243 [0.079] mm2 for mild to moderate nonproliferative DR, and 0.359 (0.275) mm2 for severe nonproliferative DR or proliferative DR. Mean (SD) EAA in whole inner retinal slab in these groups, respectively, were 0.020 (0.031) mm2, 0.034 (0.047) mm2, 0.038 (0.040) mm2, and 0.237 (0.235) mm2. The mean (SD) sum of EAA from 3 segmented plexuses in each of the respective groups were 0.103 (0.169) mm2, 0.213 (0.242) mm2, 0.451 (0.243) mm2, and 1.325 (1.140) mm2. With specificity fixed at 95%, using EAA in inner retinal slab, the sensitivity of detecting patients with diabetes from healthy control individuals was 28% (95% CI, 18%-40%), 31% for patients with DR (95% CI, 19%-45%), and 47% for patients with severe DR (95% CI, 29%-65%) from whole inner retinal EAA. With the sum of EAA from 3 individual plexuses, the sensitivities were 69% (95% CI, 57%-80%), 82% (95% CI, 70%-91%), and 97% (95% CI, 85%-100%), respectively. Avascular areas were not associated with signal strength index. The commercial vessel density from the 2-plexus scheme distinguished the groups with lower sensitivity and were dependent on SSI.
Automatically quantified avascular areas from a 3-layer segmentation scheme using PR-OCTA distinguished levels of retinopathy with a greater sensitivity than avascular areas from unsegmented inner retinal slab or measurements from a commercially available vessel density in 2-layer scheme. Additional studies are needed to investigate the applicability of nonperfusion parameters in clinical settings.
糖尿病性视网膜病变(DR)是导致视力丧失的主要原因,主要通过视网膜的定性临床检查来进行治疗。光相干断层扫描血管造影术(OCTA)可能提供一种评估 DR 的客观和定量方法。
使用投影分辨 OCTA(PR-OCTA)定量评估患有不同严重程度糖尿病性视网膜病变的患者黄斑区 3 个血管丛的毛细血管无灌注。
设计、地点和参与者:在一个三级学术中心进行的横断面研究,包括健康对照个体和不同严重程度视网膜病变的糖尿病患者的每只眼各 1 只。数据采集和分析在 2015 年 1 月至 2017 年 12 月之间进行。
中心凹无血管区面积、中心凹外无血管区(EAA)和检测视网膜病变水平的敏感性。
研究包括 39 名健康对照个体(20 名女性[51%];平均[标准差]年龄,43.41[19.37]岁);16 名无糖尿病性视网膜病变的糖尿病患者(8 名女性[50%];平均[标准差]年龄,56.50[12.43]岁);23 名轻度至中度非增生性 DR 患者(18 名女性[78%];平均[标准差]年龄,62.48[10.55]岁);和 32 名严重非增生性 DR 或增生性 DR 患者(12 名女性[38%];平均年龄,53.41[14.05]岁)。健康对照个体的平均(标准差)中心凹无血管区面积为 0.203(0.103)mm2,无糖尿病性视网膜病变的糖尿病患者为 0.192(0.084)mm2,轻度至中度非增生性 DR 为 0.243(0.079)mm2,严重非增生性 DR 或增生性 DR 为 0.359(0.275)mm2。这些组中全内视网膜板的平均(标准差)EAA 分别为 0.020(0.031)mm2、0.034(0.047)mm2、0.038(0.040)mm2 和 0.237(0.235)mm2。相应组中 3 个分段丛的 EAA 总和的平均值(标准差)分别为 0.103(0.169)mm2、0.213(0.242)mm2、0.451(0.243)mm2 和 1.325(1.140)mm2。特异性固定在 95%,使用内视网膜板的 EAA,从健康对照个体中检测出糖尿病患者的敏感性为 28%(95%CI,18%-40%),DR 患者为 31%(95%CI,19%-45%),严重 DR 患者为 47%(95%CI,29%-65%))从全内视网膜 EAA。使用 3 个单独丛的 EAA 总和,敏感性分别为 69%(95%CI,57%-80%)、82%(95%CI,70%-91%)和 97%(95%CI,85%-100%)。无血管区与信号强度指数无关。商业血管密度从 2 层方案区分了敏感性较低的组,并且依赖于 SSI。
使用 PR-OCTA 从 3 层分割方案自动量化的无血管区域与未分割的内视网膜板的无血管区域或 2 层方案中商业可用血管密度的测量相比,以更高的敏感性区分了视网膜病变的水平。需要进一步研究非灌注参数在临床环境中的适用性。